Skip to Main Content

Paper Details

Transcription Factor Activities Enhance Markers of Drug Sensitivity in Cancer.
Cancer Res
120
2018
448, Cancer, RNA-seq, cancer, cancer cell lines, cell line, cell lines, homozygous gene deletions, patient, pharmacogenomic, shRNA, tumor, tumors
Author NameAffiliation
Angela Matchan
Angela MatchanWellcome Trust Sanger Institute
Nuno A FonsecaEuropean Molecular Biology Laboratory - European Bioinformatics Institute
Patricia JaaksWellcome Trust Sanger Institute
Cyril H BenesMassachusetts General Hospital
Ian DunhamEuropean Molecular Biology Laboratory - European Bioinformatics Institute
Ian Dunham
Ian DunhamEuropean Molecular Biology Laboratory - European Bioinformatics Institute
Ian Dunham
Mathew J Garnett
Mathew J GarnettWellcome Trust Sanger Institute
Julio Saez-RodriguezEuropean Molecular Biology Laboratory - European Bioinformatics Institute
Julio Saez-Rodriguez
Julio Saez-RodriguezJoint Research Centre for Computational Biomedicine (JRC-COMBINE), RWTH Aachen University
  • 1 - 14

Datasets

Release 1.2